Advertisement
Advertisement
April 28, 2013
FDA Clears Teleflex's Arrow VPS G4 Device
April 29, 2013—Teleflex Incorporated (Limerick, PA) announced that its Arrow VPS G4 vascular positioning system has received 510(k) market clearance from the US Food and Drug Administration (FDA). The Arrow VPS G4 device, which is used with the accompanying disposable Arrow VPS stylet, will be available in the United States in the second quarter of 2013.
According to the Teleflex press release, the Arrow VPS G4 device uses micro-Doppler ultrasound technology, intravascular electrocardiography, and advanced algorithms to locate the exact location of the lower third of the superior vena cava and cavo-atrial junction, which the company noted is considered the ideal location for the tip of a peripherally inserted central catheter.
The technology is designed to provide clinicians real-time information to help avoid potentially serious clinical complications such as thrombosis, arterial puncture, and vessel wall damage. The Arrow VPS G4 device has easy-to-follow symbols, and provides statement of final catheter position, improved sterile field capability, and WiFi access for integration with hospital data management systems, stated Teleflex.
Advertisement
Advertisement
